The Marked Chart Wire · Business
Novo Nordisk
Novo Nordisk raises outlook on weight loss drug demand
Novo Nordisk has improved its financial outlook, citing sustained demand for its obesity treatments Wegovy and Ozempic.
The stocks in this story
Prices from Before the open · based on Tue close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
More Business news
Novo Nordisk
Novo Nordisk raises outlook on Wegovy pill sales
Shares of the Danish pharmaceutical firm climbed after it increased its financial targets, citing robust consumer adoption of its new oral weight-loss medication.
Novo Nordisk
Novo Nordisk shares rise on strong Wegovy pill sales
Novo Nordisk shares climbed 6 percent after the company reported quarterly earnings that exceeded expectations. Sales of its Wegovy pill surpassed estimates, prompting the drugmaker to raise its outlook.
Novo Nordisk
Novo Nordisk lifts full-year outlook on strong Wegovy pill sales
Novo Nordisk reported quarterly earnings that exceeded expectations, driven by Wegovy pill sales that surpassed estimates. The company subsequently raised its full-year financial outlook.
McDonald's Earnings
McDonald's Q3 earnings preview shows lower price targets
Analysts expect McDonald's to report third-quarter earnings per share of $3.38 and revenue of $7.28 billion. While most maintain bullish ratings, they have reduced their price targets.
Uber
UBER expected to report Q3 earnings on Thursday
Analysts project Uber will post third-quarter earnings per share of $0.90 and revenue of $14.67 billion. Recent price targets from Wall Street analysts have reached $100.
Meta Bond Sale
META begins euro bond sale following US issuance
Meta has started its debut euro bond sale after completing a $15 billion US debt deal.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.